Correlation Between Edenred SA and Sartorius Stedim

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edenred SA and Sartorius Stedim at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edenred SA and Sartorius Stedim into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edenred SA and Sartorius Stedim Biotech, you can compare the effects of market volatilities on Edenred SA and Sartorius Stedim and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edenred SA with a short position of Sartorius Stedim. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edenred SA and Sartorius Stedim.

Diversification Opportunities for Edenred SA and Sartorius Stedim

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Edenred and Sartorius is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Edenred SA and Sartorius Stedim Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sartorius Stedim Biotech and Edenred SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edenred SA are associated (or correlated) with Sartorius Stedim. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sartorius Stedim Biotech has no effect on the direction of Edenred SA i.e., Edenred SA and Sartorius Stedim go up and down completely randomly.

Pair Corralation between Edenred SA and Sartorius Stedim

Assuming the 90 days trading horizon Edenred SA is expected to under-perform the Sartorius Stedim. But the stock apears to be less risky and, when comparing its historical volatility, Edenred SA is 1.21 times less risky than Sartorius Stedim. The stock trades about -0.08 of its potential returns per unit of risk. The Sartorius Stedim Biotech is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  17,470  in Sartorius Stedim Biotech on September 3, 2024 and sell it today you would earn a total of  565.00  from holding Sartorius Stedim Biotech or generate 3.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Edenred SA  vs.  Sartorius Stedim Biotech

 Performance 
       Timeline  
Edenred SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Edenred SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Sartorius Stedim Biotech 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak primary indicators, Sartorius Stedim may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Edenred SA and Sartorius Stedim Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edenred SA and Sartorius Stedim

The main advantage of trading using opposite Edenred SA and Sartorius Stedim positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edenred SA position performs unexpectedly, Sartorius Stedim can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sartorius Stedim will offset losses from the drop in Sartorius Stedim's long position.
The idea behind Edenred SA and Sartorius Stedim Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios